Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
These treatments interact with the GLP-1 receptor, supporting improved insulin secretion, regulating blood sugar levels, and reducing appetite
Dont use it if it looks cloudy or has changed color
Plus, our content is engaging and interactive, and you can get updates for up to two years at no additional charge
ABSTRACT: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic polypeptide/GLP-1 RAs are common therapies for managing diabetes and obesity, but gastrointestinal (GI) adverse effects (AEs) such as nausea, vomiting, diarrhea, and constipation frequently limit therapy
You should seek immediate medical help and inform your doctor straight away if you get symptoms such as breathing problems, swelling of face and throat, wheezing, fast heartbeat, pale and cold skin, feeling dizzy or weak
Muscle power and performance decline even faster after age 65 for women and age 70 for men
